A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (RAINIER)

Trial ID or NCT#

NCT01769196

Status

recruiting iconRECRUITING

Purpose

This study is to evaluate the efficacy and safety of simtuzumab (GS-6624) in adults with idiopathic pulmonary fibrosis.

SEND MESSAGE

View on ClinicalTrials.gov